NuVasive Shareholder Alert: Former SEC Attorney Willie Briscoe And Powers Taylor LLP Investigate Possible Breaches Of Fiduciary Duty By Officers And Directors

Former United States Securities and Exchange Commission attorney Willie Briscoe, founder of The Briscoe Law Firm, PLLC, and the securities litigation firm of Powers Taylor LLP announce that a federal class action lawsuit has been filed against NuVasive, Inc. (“NuVasive” or “Company”) (NasdaqGS: NUVA) and several of its officers and directors for acts taken place during the period of October 22, 2008 to July 30, 2013 (the “Class Period”).

Based upon the allegations in the class action, the firms are investigating additional legal claims against the officers and Board of Directors of NuVasive. If you are an affected NuVasive shareholder and want to learn more about the lawsuit or join the action, contact Willie Briscoe at The Briscoe Law Firm, PLLC, (214) 706-9314, or via email at WBriscoe@TheBriscoeLawFirm.com, or Zach Groover at Powers Taylor LLP, toll free (877) 728-9607, via e-mail at shareholder@powerstaylor.com. There is no cost or fee to you.

In the complaint, the defendants are alleged to have violated certain provisions of the Securities Exchange Act of 1934. Specifically, the complaint alleges that defendants misrepresented and/or failed to disclose that, among other things: (a) the Company inappropriately submitted false claims to Medicare and Medicaid, which violated federal and state laws and regulations; and (b) due to the above, the Company’s statements were materially false and misleading at all relevant times. According to this complaint, when these facts were finally revealed to the market, NuVasive’s shares dropped dramatically.

“The allegedly improper business practices conducted by NuVasive have prompted our firms to investigate additional claims against the Company’s officers and directors, including potential breaches of fiduciary duties and other violations of state law. Based on our investigation, we are prepared to pursue litigation to preserve the company and the value of NuVasive stock for all shareholders,” said shareholder rights attorney Patrick Powers.

If you liked this article you might like

Biotech Movers: Cesca Up Strong After Securing CAR-T Cell Patent

Masimo's Stock Is a Great Buy Right Now

NXPI, AAPL, C: Jim Cramer's Views

Cramer: Demand Lifts Defense, Aerospace, Cyber-Security, Regional Bank Stocks

NuVasive (NUVA) Stock Tumbles on Q3 Revenue Miss, Outlook